• share
• favorite_border

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

• share
• favorite_border

• share
• favorite_border

Today, Penn Medicine celebrated the groundbreaking of the Roberts Proton Therapy Center at Penn Presbyterian Medical Center in University City, which is expected to open for patient care in late 2027.

• share
• favorite_border

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make one of the most aggressive forms of melanoma more treatable.

• share
• favorite_border

An international phase 3 clinical trial led by Washington University School of Medicine in St. Louis and Dana-Farber Brigham Cancer Center shows that patients with certain locally advanced head and neck cancers benefited from the addition of the immunotherapy drug pembrolizumab (brand name Keytruda) to standard-of-care therapy. Patients who received pembrolizumab saw greater tumor shrinkage prior to surgery and, on average, survived cancer-free almost two years longer than did patients who only received standard-of-care therapy.

• share
• favorite_border

Patients with advanced non-small cell lung cancer (NSCLC) are often treated with immunotherapy drugs known as checkpoint inhibitors, which are designed to strengthen the immune system鈥檚 ability to kill cancer cells 鈥� but these drugs do not produce a lasting response in most patients with this cancer type.

• share
• favorite_border

Ludwig Cancer Research released today the full scope of research to be presented by Ludwig-affiliated scientists at the American Association for Cancer Research (AACR) Annual Meeting 2025, which will be held online and in person in Chicago, from April 25 to April 30.

• share
• favorite_border

Indiana University School of Medicine scientists have developed a new imaging technique to study bone marrow in mouse models. This advancement could support future drug development and therapies for conditions involving bone marrow, including cancers, autoimmune diseases and musculoskeletal disorders.

• share
• favorite_border

Immunologist Shane Crotty, Ph.D., Professor and Chief Scientific Officer at La Jolla Institute for Immunology (LJI) has been elected to the American Academy of Arts and Sciences.

• share
• favorite_border

In his fourth year of study in the University of Northern Colorado鈥檚 (UNC) Sport and Exercise Science Ph.D. 鈥� Exercise Physiology Concentration program, Edwin Rodriguez is embarking on research for cancer patients.

• share
• favorite_border

Australian and Dutch researchers have uncovered a remarkable evolutionary adaptation in birds that could hold vital clues for combating avian flu and respiratory infections in humans, including pneumonia and COVID-19.

• share
• favorite_border

In a study, University of Michigan researchers have created nanodiscs that can target cholesterol levels in GBM, starving the cancer cells and increasing survival rates of the treated mice.

• share
• favorite_border

Cedars-Sinai Department of Urology physician-investigators will present their latest research at the American Urological Association (AUA) Annual Meeting April 26-29 in Las Vegas.

• share
• favorite_border

• share
• favorite_border

A new scientific study has revealed alarming levels of toxic elements in the infamous 'Land of Fires' in Campania, an area known for having one of the highest cancer rates in Europe, even in zones previously considered uncontaminated.

• share
• favorite_border

Instead of special protection against long COVID, vaccines kept children and adolescents from developing the condition by blocking COVID-19 infections in the first place